Citations should be made in the following way: Authors. Title. Eur Respir J 2015; 46: Suppl. 59, abstract number.
Citations should be made in the following way: Authors. Title. Eur Respir J 2015; 46: Suppl. 59, abstract number.
Tuberculosis: short-course chemotherapy
Year in reviewChairs: Jan-Willem Alfenaar (Groningen, Netherlands), Graham H. Bothamley (London, United Kingdom)
Aims: To present the evidence base for improving tuberculosis treatment with current and new drugs, discuss the evidence that suggests a need for shorter-course treatments for tuberculosis, the possible reasons for the problems that may be faced in shortening tuberculosis treatment with reference to the basic science of tuberculosis and present recommendations for future trials.
Target audience: Clinicians, clinical trialists, drug development organisations, public health officials, global tuberculosis funders, and basic scientists.